Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725631 | SCV000338299 | uncertain significance | not provided | 2016-01-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725631 | SCV000621100 | uncertain significance | not provided | 2017-09-22 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the TNPO3 gene. The R286H variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The R286H variant is observed in 12/8654 (0.14%) alleles from individuals of East Asian background (Lek et al., 2016). The R286H variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species; and in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV001080992 | SCV001017839 | likely benign | Autosomal dominant limb-girdle muscular dystrophy type 1F | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001080992 | SCV003827724 | uncertain significance | Autosomal dominant limb-girdle muscular dystrophy type 1F | 2021-01-07 | criteria provided, single submitter | clinical testing |